Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 1).
Patarca R, Isava A, Campo R, Rodriguez NJ, Nunez E, Alter M, Marchette M, Sanabia MM, Mitchell C, Rivera D, Scott G, Jayaweera D, Moreno J, Boulanger C, Kolber M, Mask CW, Sierra EM, Vallejo R, Page JB, Klimas NG, Fletcher MA. Patarca R, et al. Among authors: kolber m. J Environ Pathol Toxicol Oncol. 2003;22(3):201-34. doi: 10.1615/jenvpathtoxoncol.v22.i3.40. J Environ Pathol Toxicol Oncol. 2003. PMID: 14529094 Review.
Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 2).
Patarca R, Isava A, Campo R, Rodriguez NJ, Nunez E, Alter M, Marchette M, Sanabia MM, Mitchell C, Rivera D, Scott G, Jayaweera D, Moreno J, Boulanger C, Kolber M, Mask CW, Sierra EM, Vallejo R, Page JB, Klimas NG, Fletcher M. Patarca R, et al. J Environ Pathol Toxicol Oncol. 2003;22(4):235-79. doi: 10.1615/jenvpathtoxoncol.v22.i4.10. J Environ Pathol Toxicol Oncol. 2003. PMID: 14669906 Review.
Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naïve patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy.
Jayaweera DT, Kolber MA, Brill M, Tanner T, Campo R, Rodriguez A, Chu HM, Garg V. Jayaweera DT, et al. Among authors: kolber ma. HIV Med. 2004 Sep;5(5):364-70. doi: 10.1111/j.1468-1293.2004.00236.x. HIV Med. 2004. PMID: 15369512 Free article.
80 results